h ttp : / / w w w . b j m i c r o b i o l . c o m . b r /
Food
Microbiology
In
vitro
antimicrobial
and
antimycobacterial
activity
and
HPLC–DAD
screening
of
phenolics
from
Chenopodium
ambrosioides
L.
Roberta
S.
Jesus
a,∗,
Mariana
Piana
a,
Robson
B.
Freitas
a,
Thiele
F.
Brum
a,
Camilla
F.S.
Alves
a,
Bianca
V.
Belke
a,
Natália
Jank
Mossmann
a,
Ritiel
C.
Cruz
a,
Roberto
C.V.
Santos
b,
Tanise
V.
Dalmolin
c,
Bianca
V.
Bianchini
c,
Marli
M.A.
Campos
c,
Liliane
de
Freitas
Bauermann
a,∗aUniversidadeFederaldeSantaMaria,DepartamentodeFarmáciaIndustrial,LaboratóriodePesquisaFitoquímica,SantaMaria,RS,
Brazil
bCentroUniversitárioFranciscano,LaboratóriodePesquisaemMicrobiologia,SantaMaria,RS,Brazil
cUniversidadeFederaldeSantaMaria,DepartamentodeAnáliseClínicaeToxicológica,LaboratóriodePesquisaMycobacteriana,Santa
Maria,RS,Brazil
a
r
t
i
c
l
e
i
n
f
o
Articlehistory:Received25January2016 Accepted11February2017 Availableonline19July2017 AssociateEditor:LuisHenrique Guimarães Keywords: Amaranthaceae Antimicrobialpotential Rutin Quercetin Chrysin
a
b
s
t
r
a
c
t
Themainobjectiveofthisstudywastodemonstratetheantimicrobialpotentialofthe crudeextract and fractionsof Chenopodiumambrosioides L., popularlyknownas Santa-Mariaherb,against microorganismsofclinicalinterestbythemicrodilution technique, andalsotoshowthechromatographicprofileofthephenoliccompoundsinthespecies. ThePhytochemicalscreeningrevealedthepresenceofcardiotonic,anthraquinone, alka-loids,tanninsandflavonoids.TheanalysisbyHPLC–DADrevealedthepresenceofrutin in the crude extract (12.5±0.20mg/g), ethyl acetate (16.5±0.37mg/g) and n-butanol (8.85±0.11mg/g),whereasquercetinandchrysinwerequantifiedinchloroformfraction (1.95±0.04and1.04±0.01mg/g),respectively.Themostpromisingresultswereobtained with the ethyl acetate fraction, which inhibited a greater number of microorganisms andpresented the lowest values of MIC against Staphylococcus aureus and Enterococcus faecalis (MIC=0.42mg/mL), Pseudomonas aeruginosa (MIC=34.37mg/mL),Paenibacillus api-arus (MIC=4.29mg/mL) and Paenibacillus thiaminolyticus (MIC=4.29mg/mL). Considering mycobacterialinhibition,thebestresultswereobtainedbychloroformfractionagainstM. tuberculosis,M.smegmatis,andM.avium(MICrangingfrom156.25to625g/mL).Thisstudy proves,inpart,thatthepopularuseofC.ambrosioidesL.canbeaneffectiveand sustain-ablealternativeforthepreventionandtreatmentofdiseasescausedbyvariousinfectious agents.
©2017SociedadeBrasileiradeMicrobiologia.PublishedbyElsevierEditoraLtda.Thisis anopenaccessarticleundertheCCBY-NC-NDlicense(http://creativecommons.org/
licenses/by-nc-nd/4.0/).
∗ Correspondingauthors.
E-mails:[email protected](R.S.Jesus),[email protected](L.F.Bauermann).
https://doi.org/10.1016/j.bjm.2017.02.012
1517-8382/©2017SociedadeBrasileiradeMicrobiologia.PublishedbyElsevierEditoraLtda.ThisisanopenaccessarticleundertheCC BY-NC-NDlicense(http://creativecommons.org/licenses/by-nc-nd/4.0/).
Introduction
TheWorldHealth Organization(WHO)recommends world-wide development of research on medicinal plants for therapeuticpurposes,inordertoobtainnewpossibilitiesfor thetreatmentofdiseases,especiallyindevelopingcountries,1
considering also, the hope to identify new substances of medicinal character that may serve as raw materials for pharmaceuticalsindustries.InBraziltheuseofplantsisvery commonforthetreatmentofvariousdiseases,including bac-terialandfungalinfections,andmanystudiesareconducted todetectsecondarymetabolitesinplantswithantimicrobial propertiesasanattempttofindnewantimicrobialor antifun-galcompounds.2–4Indeed,becauseoftheincreasingbacterial
resistance,thereisaneedtosearchfornewantimicrobial sub-stancesfromalternativesources,suchasplantsusedinfolk medicine.Otherimportantsubjectstostudyaremycobacterial infections,includingthosecausedbyMycobacterium tubercu-losis,sincetuberculosiscaused8millionnewcasesand 1.8 millionfatalitiesperannumworldwide.5,6
ChenopodiumambrosioidesL.(DysphaniaambrosioidesL.)isto currentsynonymyofthespeciebelongstotheAmaranthaceae familyandispopularlyknownas“erva-de-santa-maria”.This plantisnativefromSouthAmericaanditiswidelydistributed throughout Brazil, being often used in folk medicine as antirheumatic,anti-inflammatory,antipyretic,antihelmintic, antifungal,anti-ulcerandforthetreatmentofwounds.7,8The
ointmentispreparedwiththeessentialoilofC.ambrosioides inhibited, the growth of dermathophytes and some other fungi.9,10In2009,thespeciewasaddedtothelistofNational
MedicinalPlantsofInterestinBrazil,(SUSRENISUS-BRAZIL) highlightingthe needtoincreasethe understandingofthe mechanismsbehinditsmedicinalproperties.11Therefore,itis
ofgreatimportancetoconductexperimentsinsuchspecies, to identify their phytochemical compounds with pharma-cological potential and to identifypossiblealternatives for antimicrobialtherapy,sincestudiesusingcrudeextractsand fractionsofC.ambrosioidesL.arescarce.
Materials
and
methods
Reagents
Allchemicalswereofanalyticalgrade.Solventsforthe extrac-tionsandanalyticalproceduresand,phytochemicalscreening were purchased from Merck (Darmstadt, Germany). The quercetin,chrysinand,rutinstandardswerepurchasedfrom Sigma–Aldrich (St. Louis, MO, USA). Microbiological assays were performed using Mueller-Hinton Agar and Mueller-HintonBrothfromSigma–Aldrich.
Plantcollection
TheleavesofC.ambrosioidesL.werecollectedinthecityof Uruguaiana,fromtheStateofRioGrandedoSul,Brazil (alti-tude57m,29◦latitude,4520,12S,longitude57◦40.28W)in Januaryof2013.Theexsiccatewasarchivedasspecimenin theherbariumoftheDepartamentofBiologyattheFederal
UniversityofSantaMaria,undertheregisternumberofSMDB 137015,forfuturereference.
Extractionoftheplantleaves
Plantmaterialwasdriedatroomtemperatureandpowered inaknifemill.Theleavesoftheplant(500g)were macera-tedatroomtemperaturewithethanol70%andsubjectedto adailyshake-upforaweek.Theextractwascollected and filteredand the remainingplantmaterialwas subjectedto more extraction.After filtration, the hydroalcoholicextract was evaporated underreduced pressure ina rotary evapo-ratortoremovethe ethanol.Ashareofthishydroalcoholic extractwasdriedinastove(temperaturebelow40◦C)yielding thedriedcrudeextract.Theremainingofthehydroalcoholic extractwaspartitionedwithsolventsofincreasingpolarity: chloroform,ethylacetateandn-butanol.Lastly,thefractions obtainedwerefullydriedinarotaryevaporator.
Phytochemicalscreening
Thephytochemicalscreeningfollowedaseriesof characteri-zationreactionswhichusedhydroalcoholicextract,according to.12,13 Theidentification ofalkaloidswasperformed using
Dragendorffreagent, thetechnique isbasedon the forma-tion ofprecipitatesaftertheadditionofthereagent,which demonstratesthepresencethesemetabolites.Theflavonoids wereidentifiedusingthereactionwithaluminumchloride, fil-terpaperstripsweremoistenedwithhydroalcoholicextract, afterwasaddedonedropof5%AlCl3solution,thepresence
offlavonoids wasrevealed byintensificationofthe yellow-ishgreencoloronfluorescence.Thetanninswereidentified through ofthe reaction that usedferric chloride,in which dropsof1%FeCl3solutioninmethanolwereaddedto2mLof
hydroalcoholicextract,thebluecolorindicatedthepresence oftannins.Theanthraquinonecompoundswereidentifiedby Bornträgerreaction.Briefly,wasaddedsmallfragmentofthe drug (about0.2g) inatest tubeand added 5mLofdiluted NH4OHsolution,thereactionwascharacterizedaspositiveby
pinkorreddishcoloration.Thecardiotonicheterosideswere characterized through ofthe Liebermann-Buchard reaction whereaceticanhydrideandsulfuricacidwereaddedtogether toapartofthehydroalcoholicextract.Thegreencoloration characterizedthepresenceofsteroidalnucleus,foundin car-diotonicscompounds.
HPLC–DADanalysisofpolyphenolscompounds
The analysis were performed with a Prominence Auto-Sampler (SIL-20A) equipped with Shimadzu LC-20AT (Shi-madzu, Kyoto, Japan) reciprocating pumps connected to a DGU-20A5degasserandCBM-20Aintegrator.UV-VISdetector DADSPD-M20AandSoftwareLCsolution1.22SP1wereused. Reversephasechromatographyanalyseswerecarriedoutwith aPhenomenexC-18column(4.6mm×250mm)packedwith 5mdiameterparticles,volumeinjectionwas40L,andthe gradientelutionwasconductedwithslightmodificationsin themethod.14Themobilephaseconsistsofwatercontaining
2.0%aceticacid(phaseA)andmethanol(phaseB),andthe elutiongradientwas2mintoachieve5%ofB,andchanged toobtain25%,40%,50%,60%,70%and100%Bat10,20,30,
40,50 and 70min,respectively. The UVabsorption spectra ofthe standards as well as the samples were recorded in therangeof230–400nm. Stocksolutionsofstandardswere preparedin methanol in the range of 0.0025–0.060mg/mL. Samplesandstandardssolutionsaswellasthemobilephase weredegassedandfilteredthrough0.45mmembranefilter (Millipore).Chromatographicoperations werecarriedout at ambienttemperature(22◦C)andintriplicate.The identifica-tionofthecompoundswasdonebycomparingitsretention timeandUVabsorptionspectrumwiththestandards.
Antimicrobialpotential
Samplepreparation
Thesampleforthemicrobiologicaltestswaspreparedfrom therawextractofC.ambrosioidesL.attheconcentrationof 275mg/mLmixedinavortexmixerandtotallydissolvedin DMSOwiththeaidofultrasound.
Microorganismsandpreparationofinoculums
Thefollowingmicroorganismsusedinthe evaluationwere obtainedfrom theAmerican TypeCultureColletion(ATCC): Bacillus cereus (ATCC 9634), Listeria monocytogenes (ATCC 7644),Enterococcusfaecalis(ATCC29212),Staphylococcusaureus (ATCC 25923), Escherichia coli (ATCC 35218), Pseudomonas aeruginosa (ATCC 340), Salmonella choleraesuis (ATCC 10708), Candida albicans (ATCC 90028). Clinical and environmental isolatesprovided bythe Department of Microbiology,from the Universidade Franciscana (UNIFRA), were also used to test the antimicrobial activity of C. ambrosioides L. extract andfractions:Paenibacillusthiaminolyticus,Paenibacilluspabuli, Paenibacillus azotofixans, Paenibacillus allginolyticus, Paenibacil-lus validus, Saccharomyces sp., Staphylococcus saprophyticus, Salmonellaenteritidis,Citrobacterfreundii,Klebsiellapneumoniae, Streptococcussp.Allisolatesweremaintainedonnutrientagar slants at4◦C.Theinoculum of the testedmicroorganisms waspreparedaccordingtotheguidelinesoftheClinicaland LaboratoryStandardsInstitute,15 adjustedto0.5McFarland
standard.
Diskdiffusiontestanddeterminationofminimalinhibitory
concentrations(MICs)
The disk diffusion test was chosen as the screening test, followingCLSIparameters,aimingtheselectionofsensitive microorganismstotheextractandfractionsfromtheleaves ofC.ambrosioidesL.Theminimuminhibitoryconcentrations (MICs)weredeterminedbythemicrodilutiontechnique,using Mueller–Hinton broth(Difco). Theassay wascarried out in 96-well microtitre plates. Each extract was mixed with an inoculumpreparedinthesamemediumatadensityadjusted per tube to 0.5 of the McFarland scale (1.5×108CFU/mL) and theactiveextracts/fractions were dilutedtwofold seri-allyranging.Microtitretrayswereincubatedat37◦Candthe MICs were recorded after 24h ofincubation. TheMIC was definedasthelowestconcentrationofextractthatinhibited bacterialgrowth.Thistestwasperformedintriplicate.The 2,3,5-triphenyltetrazoliumchloridewasusedasanindicator ofmicrobialgrowth.
Table1–Phytochemicalscreeningofhydroalcoholic extractC.ambrosioidesleaves.
Chemicaltest Result
Cardiotonics ++
Antraquinonics +
Alkaloids +
Tannins +
Flavonoids ++
Key:+,smallquantity;++,abundant.
AntimicrobialassayonMycobacterium
Antimycobacterial activity was evaluated against Mycobac-terium avium LR541CDC, Mycobacterium tuberculosis H37Rv (ATCC 25618) and Mycobacterium smegmatis mc2 155 (ATCC
700084). The suspensions were standardized through the range 0.5MacFarland scale andthen dilutedwith Middle-brook 7H9 (MD7H9), supplemented with 10% OADC (oleic acid-albumin-dextrose-catalase)and0.2%glycerol,untilthe concentration of 105 UFC/mL. Plant extracts, fractions and
standardChrysinweredissolvedinDMSO(dimetilsulfoxide), ataconcentrationof50.00mg/mLandthendilutedinMD7H9 untilthedesiredconcentration(2.500g/mL)forthe execu-tion ofthetestintriplicate.Thetestwasperformedbythe methodofbrothmicrodilutionaccordingtoCLSIM7-A6.The platescontainingM.smegmatiswereincubatedduring48h,M. aviumfor5daysandforM.tuberculosisfor7days,at37◦C.In ordertoverifytheexistence,ornot,ofmicrobialgrowth,MTT dyewasused.Followingthisprocedure,itwasconsideredas MICthelowestconcentrationoftheextractundertest capa-bleofinhibitingthegrowthofthemicroorganismsusedinthe assay.
Results
Phytochemicalscreening
Phytochemicalscreeningofhydroalcoholicextractfromthe leavesofC.ambrosioidesL.revealedthepresenceofimportant secondarymetabolitesshowedinTable1.
HPLC–DADanalysisofpolyphenolscompounds
The crude extract and chloroform, ethyl acetate and butanol fractions from the leaves of C. ambrosioides L. were analyzed by HPLC–DAD. Chromatographic profile of the crude extract, ethylacetateand butanol fractions pre-sented rutin, chloroform fraction furnished quercetin and chrysin (Fig. 1). Rutin, quercetin and chrysin were quan-tified by HPLC–DAD, based on the reference standard curves (Table 2), where calibrations curves were: rutin y=72823x−1901 (r=0.9982), quercetin y=187893x−163671 (r=0.9984)andchrysiny=148116x+62256(r=0.9988).
Antimicrobialpotential
Antimicrobialandantimicobacterialactivity
Theextractandfractionsweretestedatastandardized con-centrationof275mg/mLandtheresultsareshowninTable3.
A
1
1
1
4
3
1
200 750 500 300 200 100 1250 750 500 250 0 0 250 0 150 100 50 400 300 200 100 0 0 0.0 25.0 0.0 25.0 mAU mAU mAU mAU mAU 50.0 min 50.0 0.0 25.0 50.0 min min 0.0 25.0 50.0 min 0.0 25.0 50.0 minB
2
3
4
D
C
E
Fig.1–PhenolicprofileofC.ambrosioidesleaves:Crudeextract(A,=365nm),chloroformfraction(B,=313nm),ethyl acetatefraction(C,=365nm),n-butanolfraction(D,=365nm)andstandardcompounds(e,=254nm):rutin(1), unidentifiedpeak(2),quercetin(3)andcrhysin(4).Chromatographicconditionsdescribedintheexperimentalsection.
Table2–CompositionofChenopodiumambrosioidesleaves.
Crudeextractandfractions Rutin(mg/gofdryfraction) Quercetin(mg/gofdryfraction) Chrysin(mg/gofdryfraction)
Crudeextract 12.5±0.20 ND ND
Chloroform ND 1.95±0.04 1.04±0.01
Ethylacetate 16.5±0.37 ND ND
n-butanol 8.85±0.11 ND ND
ND,notdetected.
Allfractionswereactiveagainstimportantmicroorganisms; however, the most promising results were obtained with theethylacetatefraction,whichinhibitedagreaternumber ofmicroorganisms andpresentedthelowest valuesofMIC againsttheS.aureus,P.aeruginosa,E.faecalis,Paenibacillus api-arusandP.thiaminolyticus(rangingfrom4.29to34.37mg/mL). Considering the activities of the extract and fractions againstMycobacteriumgenus,thebestresultsandthelowest MICwereobtainedbychloroformfractionagainstM. tubercu-losis,M.smegmatis,andM.avium(MICrangingfrom156.25to 625g/mL,respectively,Table4).
Discussion
In 2009, the Brazilian Ministry of Health elaborated the National List of Medicinal Plants ofInterest in the Health
System(RENISUS),whichencouragesresearchonmedicinal plantswidelyusedamongtheBrazilianpopulation.C. ambro-sioidesL.integratesthislist;thusmotivatingtheidentification of its compounds with pharmacological potential. Phyto-chemicalscreeningofC.ambrosioidesrevealedthepresence of cardiotonics and antraquinonics, alkaloids, tannins and flavonoids; theseresults were similar tothose reportedby Nedialkovaetal.8
ThecompoundsverifiedbyHPLCanalysissuchasrutin, quercetinandchrysincanbeexplainedbythedifferencesof polaritybetweenthefractionsandthecompounds,sincerutin isa glycosideofquercetin, beingmorepolar than its agly-cone.Inthesameway,sequentialextractionswithsolventsof crescentpolaritycanprovideaselectiveextraction,basedon chemicalcharacteristicsofsecondarymetabolites.16Ina
pre-viousstudythattracedachromatographicprofileofthecrude extractfromaerialparts(leavesandflowers)ofC.ambrosioides
Table3–CorrelationbetweenthehaloofinhibitionfromeachmicroorganismassociatedtoMICvalueandmicrobial activityofrutin(compounddetectedfromHPLCanalysis).
Extractsandfractions Bacterial isolates (ATCC) Zoneof inhibition (mm) MIC(mg/mL) RutinMIC (mg/mL) DMSO Antimicrobial agent(g/mL)
Crudeextract E.faecalis 29212 16 4.29 0.56 0 2
P.apiarus CI 14 17.18 1.13 0 0.39 P.aeruginosa 340 12 68.75 0.56 0 4 Chloroform E.faecalis 29212 12 4.29 0.56 0 2 S.aureus 25923 14 8.58 0.56 0 0.06 P.apiarus CI 16 4.29 1.13 0 0.39 P.thiaminolyticus CI 14 4.29 1.13 0 0.39 P.aeruginosa 340 10 68.75 0.56 0 4
Ethylacetate E.faecalis 29212 12 4.29 0.56 0 2
S.aureus 25923 17 4.29 0.56 0 0.06 P.apiarus CI 14 4.29 1.13 0 0.39 P.thiaminolyticus CI 14 4.29 1.13 0 0.39 P.aeruginosa 340 11 34.37 0.56 0 4 n-butanol S.aureus 25923 16 34.37 0.56 0 0.06 P.aeruginosa 340 12 17.18 0.56 0 4
CI,clinicalisolate.
Table4–Minimalinhibitionconcentration(g/mL)ofcrudeextractandfractionsfromtheleavesofC.ambrosioides,
againstM.smegmatis,M.tuberculosisandM.avium.
Extractandfractions M.smegmatis(ATCC700084) M.avium(LR541CDC) M.tuberculosis(ATCC25618) Crudeextract 625g/mL >2500g/mL 1250g/mL Chloroform 312.5g/mL 625g/mL 156.25g/mL Ethylacetate 312.5g/mL >2500g/mL 1250g/mL n-butanol 625g/mL >2500g/mL 1250g/mL Crysin >2500g/mL >2500g/mL >2500g/mL Isoniazid 0.78 0.78 <0.25 DMSO 0 0 0
L.by HPLC–DAD,trans p-coumaric acid, quercetin dirham-noside,kaempferol-O-rhamnosyl-glucuronideandrutinwere identifiedandheldresponsiblefortheantimicrobialactivity verified.17Thepresentstudyreportsthepresenceofquercetin
andchrysinforthefirsttimeinthisplant.Itisofparticular interestthepresenceofchrysin,whichisreportedtohave sev-eralbiological activities,including antioxidant, anti-allergic andanti-inflammatory,besidesastronginhibitoryeffecton PGE2andTXB2productioninhumanblood,andthisproperty couldbeusedtosearchitschemicalstructureasalead com-poundinthedevelopmentofCOXinhibitors.18Theaglycones
quercetinandchrysinwerequantifiedonlyinthechloroform fraction,whereastherutinwasdetectedandquantified ran-gingfrom4.5to8.5timesgreaterthanquercetininbutanolic fraction,crudeextractandethylacetatefraction,andthislast onefurnishedthe largest amountofrutin per gramofdry fraction.
Manystudieshighlightthepotentialofnaturalcompounds against pathogens that cause severe infections such as S. aureus, P. aeruginosa, and E. faecalis, this last being consid-ered,oneofthemostprevalentspeciesculturedfromhumans; isolationofEnterococcusresistanttomultipleantibioticshas becomeincreasinglycommoninthehospitalsetting. Conse-quently,microbialresistancedemandsnewpharmacological alternatives, which led to the testing of the crude extract
andfractionsfromtheleavesofC.ambrosioidesagainstsome pathogenicmicroorganisms.
Standard rutin showed the best results against these microorganisms,corroboratingtheassumptionthatthis gly-cosidecontributes,atleastinpart,totheantimicrobialactivity observedinethylacetatefractionoftheC.ambrosioidesL.; fur-thermore,rutinisabletoincreasetheantibacterialactivityof othercompounds.19,20Commercialstandardrutinwastested
ataconcentrationof4.53mg/mL,sincethisvalueis propor-tionaltotheconcentrationofrutinobtainedinthefraction thatpresentedthehighestantimicrobialactivity(ethylacetate fraction).
PreviousstudieswithC.ambrosioidesextractsalsorevealed antimicrobialpotentialagainstpathogenssuchasS.aureus, P.aeruginosa,Brevibacillusagri,Trichophytonmentagrophytes,C. albicans(MICsrangingfrom0.25to0.80mg/mL).21Moreover,
the capacity of the plant extract to inhibit M. tuberculosis growthwastested,affordingaMICvalueof0.5.mg/mL.22The
aforementionedresultsareinaccordancewiththeresultsof thestudy,infacttheextractfromthis researchexhibiteda strongerantimycobacterialactivitythantheextractpresented inthepreviousworkmentioned.
Chromatographic profile of this fraction evidenced the presenceofthe aglyconesquercetinand chrysin.Quercetin possessesantimicrobialpropertiesagainstGram-negativeand
Gram-positivebacteriaandshowsvariableinhibitoryactivity against mycobacteria.23 In this study, chrysin was
evalu-atedandshowednoactivityagainstmycobacteria(Table4), furnishing a MIC value above the highest tested concen-tration of2.500g/mL. Also, the research group previously tested standard quercetin against M. smegmatis, obtaining MIC=625g/mL, whichindicated that other different com-pounds might be acting to increase the activity of this fraction.Inlinewiththesefindings,rutinwhosepresencewas evidenced incrudeextract, ethylacetateand butanol frac-tionsshowed aMICof625g/mLwhenassayedagainstM. smegmatis4;therefore,itisunlikelythatrutinandcrisinarethe onlycompoundsexertingtheobservedantimicrobialactivity. The phenolic compounds present in medicinal plants areresponsibleforarangeofbiologicalactivities,including antimicrobialaction.Flavonoids areagroupofheterocyclic organic compounds and constitute an important class of polyphenols. Many biological properties offlavonoids have beenreportedontheirantimicrobialpotential.Studiesreport theantimicrobialpotentialofphenolic compoundssuchas rutin,quercetinandchrysinthroughofthepermeationand destabilizationofthe bacterial membrane, resulting inthe disturbance of the proton motive force, the electron flow, coagulationandleakageofthecellularcontentcausinga bac-tericidaleffect.24–26
Crude extract and fractions from C. ambrosioides L. leavespossessimportantphytochemicalcompounds(rutin, quercetinandchrysin)whichcouldberelatedtoitspopular medicinaluse.Additionally,thisspeciesprovedtobeactive againstpathogensofclinicalinterest,suchasS.aureus,E. fae-calis,P.aeruginosaandM.tuberculosis.TheherbofSantaMariais widelyusedinfolkmedicineforthemostdiversepurposes,27
mainlyasnaturalantimicrobialaidingintheprocessofwound healing,forthisreasonwasinsertedinRENISUS.
Theresults confirm, inpart, the popular medicinal use thisspecies,duetoantimicrobialactivity,especiallyagainst cutaneous opportunistic pathogens. In addition, relevant pharmacologicalactivityagainststrainsofM.tuberculosiswere showed,contributing,thisway,intheelucidationofitsuse intuberculosis.Takingtogether,theseresultsencouragethe continuationofourstudiesaimingtoobtainpurebioactive compoundsagainstresistantmicroorganismsandbiofilm for-mers.
Conflicts
of
interest
Theauthorsdeclarenoconflictsofinterest.
Acknowledgments
TheauthorswouldliketothankProf.Dra.MargarethLinde Athayde for the orientation and support to conduct of this work, and Prof. Dr. Renato Aquino Záchia for provid-ing the identification of Chenopodium ambrosioides L. The authorsthankthefinancialsupportofCAPES(Coordenac¸ão deAperfeic¸oamentodePessoaldeNívelSuperior),Brazil.
r
e
f
e
r
e
n
c
e
s
1.GilaniAH,RahmanAU.Trendsinethnopharmocology.J
Ethnopharmacol.2005;100(1–2):43–49.
2.NascimentoGGF,LocatelliJ,FreitasPC,SilvaGL.Antibacterial
activityofplantextractsandphytochemicalsonantibiotic
resistantbacteria.BrazJMicrobiol.2000;31:247–256.
3.Stankovi ´cMS,Stefanovi ´cO, ˇComi ´cL,Topuzovi ´cM,Radojevi ´c
R,SlavicaS.Antimicrobialactivitytotalphenoliccontent
andflavonoidconcentrationsofTeucriumspecies.CentEurJ
Biol.2012;7(4):664–671.
4.DaCruzRC,AgerttV,BoligonAA,etal.Invitro
antimycobacterialactivityandHPLC–DADscreeningof
phenolicsfromFicusbenjaminaLandFicusluschnathiana(Miq)
Miqleaves.NatProdRes.2012;26:2251–2254.
5.DyeC.Globalepidemiologyoftuberculosis.Lancet.
2006;367:938–940.
6.PauliGF,CaseRJ,InuiT,etal.Newperspectivesonnatural
productsinTBdrugresearch.LifeSci.2005;78:485–494.
7.GrassiLT,MalheirosA,SilvaCZ,etal.Frompopularuseto
pharmacologicalvalidation:astudyoftheanti-inflammatory
anti-nociceptiveandhealingeffectsofChenopodium
ambrosioidesextract.JEthnopharmacol.2013;145:127–138.
8.NedialkovaZK,NedialkovPT,NikolovSD.Thegenus
chenopodium:phytochemistryethnopharmacologyand
pharmacology.PharmacognRev.2009;3(6):280–306.
9.KishoreN,ChansouriaJPN,DubeyNK.Antidermatophytic
actionoftheessentialoilofChenopodiumambrosioidesandan
ointmentpreparedfromit.IndiaPhytotherRes.
1999;10:453–455.
10.KumarR,KumarMA,DubeyNK,TripathiYB.Evaluationof
Chenopodiumambrosioidesoilasapotentialsourceof
antifungalantiaflatoxigenicandantioxidantactivity.IntJ
FoodMicrobiol.2007;115:159–164.
11.BRASILMinistériodaSaúdeOganizac¸ãoMundialdaSaúde. Availablefrom:http://bvsmssaudegovbr/bvs/sus/pdf/
marco/msrelacaoplantasmedicinaissus0603pdf;2009
Accessed24.09.13.
12.MoreiraEA.Contribuic¸ãoparaoestudofitoquímicode
LobeliahassleriAZahlbeLobeliastellfeldiiRBraga
Companulaceae.TribunaFarm.1979;47:13–39.
13.BuvaneswariK,RamamoorthyD,VelanganniJ.Preliminary
phytochemicalandantimicrobialactivitystudiesonthe
leavesoftheIndianplantThevetianeriifoliaJuss.WorldJAgric
Sci.2011;7(6):659–666.
14.BarbosaVMF,WaczukEP,KamdemJP,etal.Phytochemical
constituentsantioxidantactivitycytotoxicityandosmotic
fragilityeffectsofCaju(Anacardiummicrocarpum).IndCrops
Prod.2014;55:280–288.
15.CLSI.MethodsforDilutionAntimicrobialSusceptibilityTestsfor
BacteriathatGrowAerobically,ninthed.ApprovedStandard M7-A6.ClinicalandLaboratoryStandardsInstitute;2008.
16.SasidharanS,ChenY,SaravananD,SundramKM,YogaL.
Extractionisolationandcharacterizationofbioactive
compoundsfromplantsextracts.AfrJTraditComplement
AlternMed.2011;8(1):1–10.
17.BarrosL,PereiraE,CalhelhaRC,etal.Bioactivityand
chemicalcharacterizationinhydrophilicandlipophilic
compoundsofChenopodiumambrosioidesL.JFunctFoods.
2013;5:1732–1740.
18.SaadawiS,JalilJ,JasamaiM,JantanI.Inhibitoryeffectsof
acetylmelodorinolchrysinandpolycarpolfromMitrellakentii
onprostaglandinE2andthromboxaneB2productionand
plateletactivatingfactorreceptorbinding.Molecules.
2012;17:4824–4835.
19.CowanMM.Plantproductsasantimicrobialagents.Clin
20.RauhaJP,RemesS,HeinonenM,HopiaA,KähkönenM,
VuorelaP.AntimicrobialeffectsofFinnishplantextracts
containingflavonoidsandotherphenoliccompounds.IntJ
FoodMicrobiol.2000;56:3–12.
21.MabonaU,ViljoenA,ShikangaE,MarstonA,VanVuurenS.
AntimicrobialactivityofsouthernAfricanmedicinalplants
withdermatologicalrelevance:froman
ethnopharmacologicalscreeningapproachtocombination
studiesandtheisolationofabioactivecompound.J
Ethnopharmacol.2013;148:45–55.
22.LallN,MeyerJJM.Invitroinhibitionofdrug-resistantand
drug-sensitivestrainsofMycobacteriumtuberculosisby
ethnobotanicallyselectedSouthAfricanplants.J
Ethnopharmacol.1999;66:347–354.
23.LechnerD,GibbonsS,BucarF.Modulationofisoniazid
susceptibilitybyflavonoidsinMycobacterium.Phytochem
Lett.2008;1:71–75.
24.CushnieTPT,LambAJ.Recentadvancesinunderstanding
theantibacterialpropertiesofflavonoids.IntJAntimicrob
Agents.2011;38:99–107.
25.AhmedSI,HayatMQ,TahirM,MansoorQ,KeckMIK,BatesR.
Pharmacologicallyactiveflavonoidsfromtheanticancer,
antioxidantandantimicrobialextractsofCassiaangustifolia
Vahl.BMCComplementAlternMed.2016;16:460.
26.SarithaK,RajeshA,ManjulathaK,SettyOH,YenuguS.
Mechanismofantibacterialactionofthealcoholicextracts
ofHemidesmusindicus(L.)R.Br.ExSchult,Leucasaspera
(Wild.),PlumbagozeylanicaL.,andTridaxprocumbens(L.)R.Br.
exSchult.FrontMicrobiol.2015;6:1–9.
27.PenidoAB,MoraisSM,RibeiroAB,SilvaAZ.Ethnobotanical
studyofmedicinalplantsinImperatriz,StateofMaranhão,